RS
STRO icon

R Squared’s Sutro Biopharma STRO Stock Holding History

R Squared’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119
Closed -$2.19K – 1358
2024
Q4 		$2.19K Buy
+119
New +$3.63K ﹤0.01% 1455

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

R Squared's STRO Position: Q1 2025 in Review

R Squared sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 119 shares — an estimated $2.19K sold.

R Squared first reported a position in STRO in Q4 2024 and held it in 1 quarter. The position peaked at $2.19K in Q4 2024. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • R Squared reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 119 Sutro Biopharma shares in Q1 2025, an estimated $2.19K.
  • R Squared first reported a position in Sutro Biopharma in Q4 2024 and held it in 1 quarter.
  • R Squared's Sutro Biopharma position peaked at $2.19K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.